Benzodiazepine effects on human sleep EEG spectra

A comparison of triazolam and flunitrazepam

Xin Tan, Sunao Uchida, Masato Matsuura, Kyoko Nishihara, Yoshinobu Iguchi, Takuya Kojima

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The effects of 0.5 mg triazolam (TRI) and 4 mg flunitrazepam (FNZ) on the sleep electroencephalogram (EEG) were studied in eleven (six for TRI, and five for FNZ) healthy young male subjects. C3 EEG channel data of one baseline night, three drug nights and two withdrawal nights were recorded and their analyzed using a fast Fourier transformation (FFT) method. Changes in the 0.5 Hz to 40 Hz power spectrum showed that: 1) both TRI and FNZ increased higher frequency activity and reduced lower frequency activity on the drug nights; 2) on drug nights, NREM sigma frequency power was more strongly enhanced by TRI than FNZ, while the beta power of both NREM and REM was more strongly enhanced by FNZ than TRI; 3) NREM alpha power increased on the second night of withdrawal from both TRI and FNZ; 4) the power spectra for both NREM and REM sleep returned to baseline levels by the fourth night of withdrawal from either TRI or FNZ. These findings suggest that 0.5 mg TRI and 4 mg FNZ have both common and differing pharmacological effects on the central nervous system. Such differences could be caused by differences in the dose, half-life or systemic distribution of these two drugs.

Original languageEnglish
Pages (from-to)675-684
Number of pages10
JournalLife Sciences
Volume63
Issue number8
DOIs
Publication statusPublished - 1998 Jul 17
Externally publishedYes

Fingerprint

Triazolam
Flunitrazepam
Electroencephalography
Benzodiazepines
Sleep
Power spectrum
Pharmaceutical Preparations
REM Sleep
Neurology
Half-Life
Central Nervous System
Pharmacology

Keywords

  • Flunitrazepam
  • Sleep EEG
  • Spectral analysis
  • Triazolam

ASJC Scopus subject areas

  • Pharmacology

Cite this

Tan, X., Uchida, S., Matsuura, M., Nishihara, K., Iguchi, Y., & Kojima, T. (1998). Benzodiazepine effects on human sleep EEG spectra: A comparison of triazolam and flunitrazepam. Life Sciences, 63(8), 675-684. https://doi.org/10.1016/S0024-3205(98)00318-X

Benzodiazepine effects on human sleep EEG spectra : A comparison of triazolam and flunitrazepam. / Tan, Xin; Uchida, Sunao; Matsuura, Masato; Nishihara, Kyoko; Iguchi, Yoshinobu; Kojima, Takuya.

In: Life Sciences, Vol. 63, No. 8, 17.07.1998, p. 675-684.

Research output: Contribution to journalArticle

Tan, X, Uchida, S, Matsuura, M, Nishihara, K, Iguchi, Y & Kojima, T 1998, 'Benzodiazepine effects on human sleep EEG spectra: A comparison of triazolam and flunitrazepam', Life Sciences, vol. 63, no. 8, pp. 675-684. https://doi.org/10.1016/S0024-3205(98)00318-X
Tan, Xin ; Uchida, Sunao ; Matsuura, Masato ; Nishihara, Kyoko ; Iguchi, Yoshinobu ; Kojima, Takuya. / Benzodiazepine effects on human sleep EEG spectra : A comparison of triazolam and flunitrazepam. In: Life Sciences. 1998 ; Vol. 63, No. 8. pp. 675-684.
@article{0ada0ae0779d4758a1484293be53e5ef,
title = "Benzodiazepine effects on human sleep EEG spectra: A comparison of triazolam and flunitrazepam",
abstract = "The effects of 0.5 mg triazolam (TRI) and 4 mg flunitrazepam (FNZ) on the sleep electroencephalogram (EEG) were studied in eleven (six for TRI, and five for FNZ) healthy young male subjects. C3 EEG channel data of one baseline night, three drug nights and two withdrawal nights were recorded and their analyzed using a fast Fourier transformation (FFT) method. Changes in the 0.5 Hz to 40 Hz power spectrum showed that: 1) both TRI and FNZ increased higher frequency activity and reduced lower frequency activity on the drug nights; 2) on drug nights, NREM sigma frequency power was more strongly enhanced by TRI than FNZ, while the beta power of both NREM and REM was more strongly enhanced by FNZ than TRI; 3) NREM alpha power increased on the second night of withdrawal from both TRI and FNZ; 4) the power spectra for both NREM and REM sleep returned to baseline levels by the fourth night of withdrawal from either TRI or FNZ. These findings suggest that 0.5 mg TRI and 4 mg FNZ have both common and differing pharmacological effects on the central nervous system. Such differences could be caused by differences in the dose, half-life or systemic distribution of these two drugs.",
keywords = "Flunitrazepam, Sleep EEG, Spectral analysis, Triazolam",
author = "Xin Tan and Sunao Uchida and Masato Matsuura and Kyoko Nishihara and Yoshinobu Iguchi and Takuya Kojima",
year = "1998",
month = "7",
day = "17",
doi = "10.1016/S0024-3205(98)00318-X",
language = "English",
volume = "63",
pages = "675--684",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Benzodiazepine effects on human sleep EEG spectra

T2 - A comparison of triazolam and flunitrazepam

AU - Tan, Xin

AU - Uchida, Sunao

AU - Matsuura, Masato

AU - Nishihara, Kyoko

AU - Iguchi, Yoshinobu

AU - Kojima, Takuya

PY - 1998/7/17

Y1 - 1998/7/17

N2 - The effects of 0.5 mg triazolam (TRI) and 4 mg flunitrazepam (FNZ) on the sleep electroencephalogram (EEG) were studied in eleven (six for TRI, and five for FNZ) healthy young male subjects. C3 EEG channel data of one baseline night, three drug nights and two withdrawal nights were recorded and their analyzed using a fast Fourier transformation (FFT) method. Changes in the 0.5 Hz to 40 Hz power spectrum showed that: 1) both TRI and FNZ increased higher frequency activity and reduced lower frequency activity on the drug nights; 2) on drug nights, NREM sigma frequency power was more strongly enhanced by TRI than FNZ, while the beta power of both NREM and REM was more strongly enhanced by FNZ than TRI; 3) NREM alpha power increased on the second night of withdrawal from both TRI and FNZ; 4) the power spectra for both NREM and REM sleep returned to baseline levels by the fourth night of withdrawal from either TRI or FNZ. These findings suggest that 0.5 mg TRI and 4 mg FNZ have both common and differing pharmacological effects on the central nervous system. Such differences could be caused by differences in the dose, half-life or systemic distribution of these two drugs.

AB - The effects of 0.5 mg triazolam (TRI) and 4 mg flunitrazepam (FNZ) on the sleep electroencephalogram (EEG) were studied in eleven (six for TRI, and five for FNZ) healthy young male subjects. C3 EEG channel data of one baseline night, three drug nights and two withdrawal nights were recorded and their analyzed using a fast Fourier transformation (FFT) method. Changes in the 0.5 Hz to 40 Hz power spectrum showed that: 1) both TRI and FNZ increased higher frequency activity and reduced lower frequency activity on the drug nights; 2) on drug nights, NREM sigma frequency power was more strongly enhanced by TRI than FNZ, while the beta power of both NREM and REM was more strongly enhanced by FNZ than TRI; 3) NREM alpha power increased on the second night of withdrawal from both TRI and FNZ; 4) the power spectra for both NREM and REM sleep returned to baseline levels by the fourth night of withdrawal from either TRI or FNZ. These findings suggest that 0.5 mg TRI and 4 mg FNZ have both common and differing pharmacological effects on the central nervous system. Such differences could be caused by differences in the dose, half-life or systemic distribution of these two drugs.

KW - Flunitrazepam

KW - Sleep EEG

KW - Spectral analysis

KW - Triazolam

UR - http://www.scopus.com/inward/record.url?scp=18844474865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18844474865&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(98)00318-X

DO - 10.1016/S0024-3205(98)00318-X

M3 - Article

VL - 63

SP - 675

EP - 684

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 8

ER -